MergerLinks Header Logo

Request Deal Involvement

Asahi Kasei completed the acquisition of Calliditas Therapeutics for $1.1bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Vinge

legal advisors

Vinge

Lazard

financial advisors

Lazard

DLA Piper

legal advisors

DLA Piper

Davis Polk & Wardwell

legal advisors to financial advisors

Davis Polk & Wardwell

Kekst CNC

pr advisors

Kekst CNC

Cleary Gottlieb Steen & Hamilton

legal advisors

Cleary Gottlieb Steen & Hamilton

or

Principals

CALLIDITAS THERAPEUTICS

target

CALLIDITAS THERAPEUTICS

ASAHI KASEI CORPORATION

bidder

ASAHI KASEI CORPORATION

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Asahi Kasei completed the acquisition of Calliditas Therapeutics for $1.1bn.